Avoid Glaucoma Surgery

Glaucoma can appear uncontrolled when medications are not being used consistently or correctly. Complex treatment schedules, poor eye drop technique, treatment fatigue, and medication side effects may raise eye pressure and mimic disease progression. A glaucoma second opinion can identify these issues before surgery is considered.

Not every patient with glaucoma needs surgery immediately. In many cases, improving eye drop technique, simplifying medications with fixed-dose combinations, or considering SLT laser treatment can achieve good pressure control and delay or avoid surgery. This is when a Glaucoma Second Opinion can help, says Dr Shibal Bhartiya.

A Word of Caution: Avoiding glaucoma surgery is NOT always advisable. In certain cases, the surgery is the only option, and helps prevent blindness. You must discuss the risks and benefits of your treatment protocol in detail with your glaucoma doctor before coming to a decision.

She Was Told She Needed Surgery

Anita, 63, had been living with glaucoma for nearly six years when she came to see me. At her previous appointment, surgery had been advised. Her eye pressure remained above target despite treatment, and recent visual field tests suggested possible progression. The changes were not dramatic, but they were concerning enough for surgery to enter the discussion.

She arrived carrying a large folder of records and four eye drop bottles.

As I reviewed her reports, I understood the concern. Her pressures were higher than ideal. A few visual field tests appeared slightly worse than earlier ones. Yet the optic nerve photographs showed only subtle change over time.

The clue had been present for months. I asked Anita to describe her treatment routine.

She was not avoiding treatment. She was trying very hard to follow it. The problem was that her regimen had gradually become more complicated. Four medications meant four separate bottles. Some needed morning doses. Others needed evening doses. During travel, one bottle might be forgotten. On busy days, she sometimes could not remember whether she had already used a drop.

Then I asked her to put in her medication. One drop landed on her cheek. Another missed the eye completely.

The glaucoma was real. The pressure problem was real. The possible progression was real.

But the patient was not failing treatment. The treatment plan was failing the patient. We simplified her regimen. Four separate medications became two fixed-dose combination bottles. We reviewed eye drop technique and built the schedule around her daily routine. Over the next three months, we achieved her target IOP, with the same medicines. Just in fewer bottles, and just because she learnt how to put them herself.

Over the last two years, her visual fields and RNFL OCT have been stable.

Patient details have been changed to protect privacy.

Here is What We Must Remember

Anita’s case highlights an important lesson. Not every patient with uncontrolled eye pressures needs glaucoma surgery. Sometimes the problem lies in how treatment is being delivered rather than the treatment itself. Glaucoma medications only work when they reach the eye consistently and correctly. Before treatment is escalated, it is important to understand whether the prescribed therapy is practical, tolerable, and sustainable. In this article, I explain why glaucoma treatment sometimes appears to fail and how a glaucoma second opinion can help.

Why Glaucoma Treatment Sometimes Appears To Fail

The goal of glaucoma treatment is simple. Lower eye pressure enough to prevent damage to the optic nerve. Achieving that goal is often more complicated.

Many patients begin treatment with a single eye drop. As glaucoma progresses, additional medications may be added. Over time, one bottle can become two, then three, then four. Each medication may have a different schedule.

For some patients, this becomes difficult to sustain.

In my practice, I commonly see patients who understand the importance of their medication but struggle with the practical realities of long-term treatment. Life gets busy. Travel happens. Schedules change. Even highly motivated patients miss doses.

Poor adherence does not always mean patients are careless. More often, it reflects treatment burden.

The clue had been present for almost a year in Anita’s case. Her pressure fluctuated more than expected. Her visual fields suggested borderline progression. Yet the optic nerve remained relatively stable. The pattern suggested that treatment effectiveness might be inconsistent.

When treatment appears to fail, specialists should ask several questions:

  • Is the diagnosis correct?
  • Is the target pressure appropriate?
  • Is the medication reaching the eye?
  • Is the patient able to follow the regimen?
  • Are side effects reducing adherence?

The answers can significantly change management.

The Importance of Eye Drop Technique

Many patients have never been shown how to use an eye drop correctly.

Common mistakes include:

  • Missing the eye completely
  • Blinking immediately after instillation
  • Using multiple drops at once
  • Touching the bottle tip to the eye
  • Administering medications too close together

Even small technique errors can reduce treatment effectiveness.

A simple demonstration often reveals problems that no scan or visual field test can detect.

Why Fixed-Dose Combinations Matter

Fixed-dose combinations combine two glaucoma medications into a single bottle.

Many patients assume these combinations are prescribed for convenience alone. In reality, they often improve treatment success.

A patient using four medications in four separate bottles may struggle with timing, scheduling, and adherence. The same medications delivered through two fixed-dose combinations can reduce confusion and simplify daily routines.

Fewer bottles often mean:

  • Better adherence
  • Less treatment fatigue
  • Lower preservative exposure
  • Greater long-term consistency

The most effective treatment is not always the strongest treatment. Often, it is the treatment a patient can realistically follow every day for years.

Could Laser Treatment Reduce the Need for Eye Drops?

For some patients, Selective Laser Trabeculoplasty (SLT) offers another way to lower eye pressure without adding more medications. SLT is a quick outpatient laser procedure that improves the eye’s natural drainage system. It does not cure glaucoma, but it can reduce eye pressure and, in some patients, decrease the number of medications needed.

This can be particularly helpful for patients who struggle with eye drop schedules, experience side effects from medications, or find long-term adherence difficult. While not every patient is a suitable candidate, SLT is increasingly being used earlier in the treatment pathway because it avoids many of the compliance challenges associated with daily eye drops. A glaucoma specialist can determine whether SLT is appropriate based on the type of glaucoma, eye pressure targets, and the overall risk of progression.

This is why a glaucoma second opinion should not focus only on surgery versus medications. For selected patients, laser treatment may offer an effective middle path.

How to Tell Glaucoma Progression From Treatment Problems

SymptomWhat It SuggestsWhat To Do
Rising eye pressure with stable optic nervePossible adherence issueReview medication use and eye drop technique within weeks
Borderline visual field progressionInconsistent treatment or early progressionRepeat visual field testing and specialist review
Multiple missed doses each weekTreatment burdenSimplify regimen and reassess pressure
Burning or redness from medicationOcular surface toxicityReview medications and ocular surface health
Difficulty managing several bottlesCompliance challengeConsider fixed-dose combinations
Progressive optic nerve damage despite good adherenceTrue disease progressionDiscuss laser or surgical options with a glaucoma specialist

Why This Diagnosis Is So Often Missed

Doctors naturally focus on disease progression. Sometimes the treatment process receives less attention.

Eye pressure is easy to measure. Medication adherence is much harder to assess. Many patients feel embarrassed to admit they miss doses. Others genuinely believe they are using their medication correctly.

Busy clinics may not have time to observe eye drop technique. Treatment burden develops gradually. Patients adapt to it until the regimen becomes overwhelming.

Preservatives in glaucoma medications may also contribute to ocular surface disease. Redness, burning, and irritation can reduce adherence further.

When eye pressure rises, it is easy to assume the disease is worsening. Sometimes the medication is simply not reaching the eye consistently.

Recognising this distinction can prevent unnecessary treatment escalation.

When To See an Eye Specialist

You should seek specialist evaluation, or a second opinion, if:

  • You have been advised glaucoma surgery and want a second opinion
  • Eye pressure remains above target despite multiple medications
  • Your visual field tests show possible progression
  • You struggle to remember or administer your eye drops
  • Your eyes burn, sting, or remain red after glaucoma treatment
  • You have been told everything is stable but symptoms continue

Frequently Asked Questions

Can poor eye drop technique make glaucoma appear worse?

Yes. If medication does not reach the eye consistently, eye pressure may remain elevated. This can create the impression that treatment is failing even when the prescription itself is appropriate.

Why might a glaucoma specialist recommend a second opinion before surgery?

A second opinion helps confirm whether glaucoma is truly progressing. It also evaluates medication adherence, eye drop technique, treatment burden, and medication tolerance before irreversible procedures are considered.

How do fixed-dose combination eye drops help glaucoma patients?

Fixed-dose combinations reduce the number of bottles and simplify treatment schedules. This often improves adherence and helps patients maintain more consistent pressure control over time.

Should glaucoma surgery be delayed if treatment adherence is poor?

Not always. Some patients genuinely require surgery. However, adherence problems, poor eye drop technique, and unnecessarily complex regimens should be identified and addressed before concluding that surgery is the only option.

Book a Consultation

Consider a consultation if you have been advised glaucoma surgery, if your eye pressure remains uncontrolled, or if your visual field tests show possible progression despite treatment.

A glaucoma consultation includes assessment of optic nerve health, visual field results, pressure trends, medication tolerance, and practical evaluation of how glaucoma medications are being used.

[Book an Appointment →+91 8882638735]


This page is a part of the Glaucoma Hub. you may want to read about Glaucoma Progression, and Risk Stratification in Glaucoma. Other articles of interest could be Advanced Glaucoma Care in Gurgaon, What Good Glaucoma Care Actually Optimises For, What Happens If Glaucoma Is Left Untreated?, More Glaucoma Eye Drops is Not Better Glaucoma Care, 5 Mistakes Patients Make in Glaucoma Care and Do You Really Need Treatment for Glaucoma?

You may also want to read Glaucoma Second Opinion — Gurgaon, Online Glaucoma Consultation and Second Opinion Before Eye Surgery.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Common Myths About Glaucoma

Most common myth about glaucoma is that it causes pain or obvious vision loss, but early glaucoma is often silent and progresses slowly. Regular eye examinations are important because glaucoma damage can occur long before symptoms become noticeable.
Patients who believe they would notice symptoms, that only older people are affected, or that treatment means surgery are the patients who present late. Here is what is true, explains Dr Shibal Bhartiya.

Glaucoma affects over 12 million people in India. The majority do not know they have it. Part of the reason is the disease itself: silent, slow, and peripheral. But part of the reason is misinformation that creates false reassurance at precisely the moment awareness matters most.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Eight Glaucoma Myths That Cost People Their Vision

MythWhat the Evidence Shows
Glaucoma only affects the elderly.While risk rises with age, glaucoma can occur at any age. Juvenile glaucoma affects teenagers. Primary open angle glaucoma is well documented in patients in their 30s and 40s, particularly in South Asian populations with high myopia or family history.
I would know if I had glaucoma — my vision is fine.Glaucoma destroys peripheral vision first. Central vision — what you use to read and recognise faces — is preserved until very late in the disease. The brain compensates for peripheral loss so effectively that patients can lose 40% of their optic nerve before noticing anything.
Glaucoma always causes high eye pressure.Normal tension glaucoma — where the optic nerve is damaged despite normal IOP — accounts for 30–40% of glaucoma in India. A normal pressure reading does not mean your optic nerve is safe.
Glaucoma means I will go blind.Glaucoma diagnosed and treated early is very unlikely to cause blindness. Most patients with well-managed glaucoma retain functional vision for life. The blindness associated with glaucoma is almost always the result of late detection or inadequate treatment.
Glaucoma treatment means surgery.The majority of glaucoma patients are managed with eye drops alone for many years. Laser procedures (SLT) are used when drops are insufficient or poorly tolerated. Surgery is reserved for cases where other treatments fail or where IOP needs to be lowered substantially.
Once I start glaucoma drops, I am on them forever.Treatment duration depends on the stage of disease, IOP response, and patient factors. Some patients transition from drops to laser. Some achieve adequate control with laser alone. Surgical treatment can reduce or eliminate drop dependence. Your specialist reviews this regularly.
Glaucoma runs in my family but I feel fine, so I must be fine.Family history of glaucoma increases your personal risk four to nine times. Feeling fine is expected — glaucoma is asymptomatic. A first-degree relative with glaucoma is the single strongest indication for annual specialist screening, regardless of how well you feel.
Glaucoma eye drops are just for reducing pressure — they have no other effect.Glaucoma drops significantly affect the eye surface, causing dry eye, redness, and allergic reactions in many patients. Some systemic drops affect heart rate and blood pressure. Your specialist needs to know your full medical history and all medications before prescribing.

Frequently Asked Questions

Is There a Cure for Glaucoma?

There is no cure for glaucoma in the sense of restoring damaged nerve tissue. The optic nerve fibres lost to glaucoma do not regenerate. Treatment halts or slows progression — it does not reverse what has already been lost. This is why early detection is the single most important determinant of outcome.

Can I Check My Own Eye Pressure at Home?

Home tonometers are available and improving, but they are not a substitute for specialist monitoring. IOP is one variable in glaucoma management. Optic nerve appearance, visual field status, and nerve fibre layer thickness are equally or more important — none of which a home device measures. Home monitoring may have a role as a supplement to specialist care, not a replacement for it.

How Often Do I Need to See a Glaucoma Specialist?

This depends on your disease stage and stability. Newly diagnosed or unstable patients are typically reviewed every three to four months. Stable patients with well-controlled IOP and no progression may be reviewed every six to twelve months. Your schedule is set by your specialist and should not be deferred because you feel well.

Does Glaucoma Affect Both Eyes Equally?

Glaucoma is often asymmetric — it begins in one eye before the other and progresses at different rates. This asymmetry is one reason patients do not notice it. The better eye compensates for the worse eye. By the time both eyes are significantly affected, the window for prevention has often closed in the first eye.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Related Reading
Get an Online Glaucoma Consult
Visual Field and OCT: Structure & Function Correlation
Glaucoma Diagnosis in Gurgaon
Risk Stratification in Glaucoma
Glaucoma Progression: What It Means and How to Slow It
Glaucoma treatment in Gurgaon
All About Glaucoma Medication
Glaucoma Lasers: SLT & LPI
Glaucoma surgery in Gurgaon
MIGS in Gurgaon
Get a Glaucoma Second Opinion in Gurgaon

Glaucoma Progressing Despite Normal Pressure: 24 Hour IOP

Glaucoma progression despite apparently controlled intraocular pressure is one of the most disorienting experiences a patient can face. It is also one of the most common reasons patients seek a glaucoma second opinion. The reason is almost always the same: daytime clinic readings capture one moment. They do not capture what happens at night, explains Dr Shibal Bhartiya.

Not all glaucoma medications lower pressure around the clock. Brimonidine and timolol both show significantly reduced activity after midnight. A patient whose pressure is controlled at 11 am may have entirely uncontrolled pressure at 3 am — and no standard clinic visit will reveal this.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

My Glaucoma Is Progressing But My Pressure Is Always Normal. What Is Going On?

He was in his early sixties — careful, informed, and deeply confused.

He came to me for a second opinion after five to six years under glaucoma care. His file was meticulous. His lifestyle was exemplary — non-smoker, controlled blood pressure, controlled blood sugars. He was on two medications: timolol and brimonidine. His baseline IOP had been 26 to 27 mmHg. On treatment, it now sat at 13 to 14 mmHg at every clinic visit for years.

By every standard measure, he was a success story. But his glaucoma was still progressing.

He was not angry. He was bewildered. I have done everything right, he told me. Why is this still happening?

That question deserved a better answer than he had been given. The answer was in the hours nobody had measured.

The question nobody had asked

I looked at his records and asked him one thing: had anyone ever done a diurnal variation for him? A 24-hour IOP measurement, mapped across day and night? Or a Water Drinking Test?

He said no.

We enrolled him in a study using the Triggerfish sensor — a contact lens device that records continuous IOP fluctuation over 24 hours. The device does not measure absolute pressure values, but it maps the pattern of fluctuation with precision.

The night-time readings were almost double the daytime values.

Most clinic visits measure pressure once, mid-morning, when he was up and about. That is the reading least likely to catch a nocturnal spike. His reassuring numbers, always 13, always 14, had been capturing only half the story. The other half was unfolding while he slept, while no one was measuring, while his optic nerve absorbed damage that nobody anticipated.

Why his medications were failing him at night

The reason was pharmacological, and it is something worth stating clearly: brimonidine and timolol do not work at night. Their pressure-lowering effect drops sharply in the late hours. His reassuring clinic readings — always 13, always 14 — had been capturing only half the story. The other half was invisible, unfolding while he slept, while no one was measuring, while his optic nerve absorbed damage that nobody anticipated.

This is not a failure of the medications. It is a failure of the measurement system — and of the assumption that a daytime number tells the whole story.

What Doctors Often Miss

Brimonidine and timolol do not work at night. This is pharmacology, not failure — their pressure-lowering effect drops sharply in the late hours. It is a well-documented limitation that is not always communicated to patients or factored into treatment decisions.

The result is that a patient can have genuinely excellent daytime control and entirely uncontrolled nocturnal pressure simultaneously. Standard clinic visits — timed to office hours — will never detect this.

The other missed step is the diurnal variation test itself. It is one of the most underused and highest-yield investigations in glaucoma management. It is rarely ordered unless a specialist specifically suspects nocturnal IOP spikes. If your glaucoma is progressing despite apparently good readings, this investigation is worth asking for by name — and a glaucoma second opinion is always reasonable in this situation.


Why Prostaglandins Are First-Line for a Reason

We switched him to bimatoprost 0.01% — a prostaglandin analogue. Prostaglandins are the only class of glaucoma medication proven to work continuously across 24 hours. They do not lose activity at night.

That was in 2012 to 2013. He has been stable for over six years.

One molecule change. One question that had never been asked. Six years of stability that five years of treatment had never delivered.


Symptoms, Pressure Patterns, and When to Investigate

FindingLikely CauseWhen to Investigate Further
Glaucoma progressing despite good clinic IOPNocturnal IOP spike not captured by daytime readingsRequest 24-hour diurnal variation assessment
On timolol or brimonidine, still progressingNight-time loss of drug efficacyAsk whether a prostaglandin has been considered
Visual field deterioration at routine reviewOngoing IOP fluctuation between clinic visitsIOP fluctuation may be as damaging as sustained elevation
Good compliance, good lifestyle, still progressingMedication class mismatch for 24-hour coverageSecond opinion from glaucoma specialist
Pressure controlled but OCT showing RNFL thinningStructural damage continuing despite IOP numbersFull diurnal assessment and treatment review

What This Means for You

If your glaucoma is progressing despite readings that look controlled, the readings may be incomplete — not the whole story, only the morning chapter.

The questions worth asking at your next visit: Has my pressure ever been measured at night? Has anyone checked whether my medications work across 24 hours? Has a prostaglandin analogue been considered as my primary medication?

You are not doing anything wrong. The measurement system may simply be missing the hours that matter most.


If your glaucoma is progressing despite treatment, or if you have never had a 24-hour IOP assessment, a specialist review may give you answers years of routine care have not.

Book a consultation or second opinion with Dr Shibal Bhartiya in Gurgaon.
+91 88826 38735 | www.drshibalbhartiya.com


FAQs

My glaucoma is progressing but my eye pressure is always normal at the clinic. How is that possible?

Clinic readings capture pressure at one moment, usually mid-morning. Eye pressure fluctuates across 24 hours. Certain medications — including timolol and brimonidine — lose effectiveness at night. If pressure spikes at 2 am, no daytime clinic visit will catch it. That spike is still damaging your optic nerve, invisibly, visit after visit.

What is a diurnal variation test and do I need one?

A diurnal variation maps your eye pressure across the full day and night. It is recommended when glaucoma is progressing despite apparently controlled pressure, when you are on medications that may not provide round-the-clock coverage, or when your specialist suspects night-time IOP spikes. It is one of the most underused and highest-yield tests in glaucoma management.

Why are prostaglandin eye drops the first choice for glaucoma?

Prostaglandins are the only class of glaucoma medication that works continuously across 24 hours. Other drugs — including timolol and brimonidine — show significantly reduced activity at night. For long-term pressure control, the night-time hours matter as much as the daytime ones. This is why prostaglandin analogues are recommended as first-line therapy in international glaucoma guidelines.

Can glaucoma progress even when I am doing everything right?

Yes, and it is more common than patients realise. Controlled daytime pressure, healthy lifestyle, medication compliance — none of these guarantee protection if night-time IOP is unaddressed. Progression despite apparent control is a signal to investigate further, not to doubt yourself. A glaucoma second opinion is always reasonable in this situation.

Should I ask for a 24-hour IOP test if my glaucoma is progressing?

Yes. If your visual fields are declining despite good clinic readings, a diurnal variation assessment is a reasonable and important next step. Ask your glaucoma specialist specifically about this. It is a question worth asking at your next visit.


This page is part of the Advanced Glaucoma Care hub. Read about the full spectrum of glaucoma diagnosis and treatment. Please also read about Diurnal Variation of IOP, Target IOP and Glaucoma Eye Drops.

You may want to watch this podcast I did several years ago, for Health Talks.


Note: Contact Lens Monitor for Continuous IOP Monitoring

Triggerfish® contact lens sensor is a specialised diagnostic contact lens used in glaucoma care to monitor intraocular pressure (IOP)–related changes over 24 hours. Unlike routine pressure measurements taken during clinic hours, the Triggerfish lens (Sensimed Triggerfish) helps detect pressure fluctuations that may occur at night or outside OPD visits, which can sometimes explain progression despite apparently controlled readings. It does not measure pressure directly in mmHg but records circumferential corneal changes related to IOP patterns, helping glaucoma specialists better understand individual risk profiles and treatment needs in selected patients.

Dr Shibal Bhartiya was the first doctor in India to use the Triggerfish® contact lens sensor for Continuous IOP Monitoring in clinical practice. Her initial experiences on Intraocular pressure (IOP) related pattern in patients with primary angle closure (PAC) and primary angle closure glaucoma (PACG) before and after laser peripheral iridotomy (LPI) was presented at ARVO, in Orlando Florida in 2014

IOP Fluctuation and Angle Closure Glaucoma

IOP fluctuation is a particular concern in angle closure disease, where pressure spikes can be steep and are frequently missed by routine daytime readings. Dr Bhartiya’s published research has examined this directly. A 2015 study in the Journal of Current Glaucoma Practice, Diurnal Intraocular Pressure Fluctuation in Eyes with Angle-Closure (Bhartiya S, Ichhpujani P; PMID: 26997828), investigated IOP fluctuation across the day in 77 newly diagnosed angle closure patients and documented the range and pattern of diurnal variation in this group.

A 2019 review in the Romanian Journal of Ophthalmology, Diurnal Variation of IOP in Angle Closure Disease: Are We Doing Enough? (Bhartiya S et al.; PMID: 31687621), went further — finding that many clinical decisions in angle closure glaucoma management are based on only one or two IOP measurements, and arguing that this is insufficient given the established circadian rhythm of IOP and its direct correlation with glaucoma progression. Taken together, these papers make the case that angle closure patients may be among the most undertreated precisely because their worst pressure moments are the least observed.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (PubMed-indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks, span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1,500+ Five Star Patient Reviews — Google Business Profile

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review. | www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Why Do I Need Glaucoma Treatment If My Vision Seems Normal?

Glaucoma often causes permanent optic nerve damage long before noticeable vision loss develops. Treatment is designed to protect your future vision by slowing or preventing progression before symptoms appear, Dr Shibal Bhartiya explains.

Your vision feels fine. No pain, no blur, no obvious change. So why is your doctor urging treatment? This is the most common question glaucoma patients ask, and it deserves a direct, honest answer,

Glaucoma destroys your optic nerve silently. By the time you notice something is wrong, you have already lost nerve fibres that will never return. Treatment does not restore what is gone. It protects what remains.


The Vision You Have Now Is Not the Vision You Started With

Glaucoma removes peripheral vision first. Your central vision stays sharp until the disease is advanced. Your brain also compensates, filling in blind areas so skilfully that you do not notice them. You may have lost 30 to 40 percent of your optic nerve fibres before any symptom appears.

This is why “I can see fine” is not a safe reassurance in glaucoma. It reflects the vision that has survived, not the vision that has been lost.


Why Glaucoma Treatment Feels Unnecessary (And Why That Feeling Is Dangerous)

Glaucoma drops do not improve your vision. They do not reduce pain because glaucoma causes none. They do not change how things look today. Their only job is to lower the pressure inside your eye and slow the damage to your optic nerve.

When a treatment produces no felt benefit, stopping it feels harmless. This is the central psychological trap in glaucoma care. Patients who feel well skip doses, delay refills, or discontinue treatment altogether. The nerve continues to deteriorate. By the time symptoms appear, the loss is severe and permanent.

The absence of symptoms is not evidence that you are safe. It is evidence that the disease has not yet crossed your threshold of awareness.


What the Research Actually Shows

Studies consistently show that controlling eye pressure reduces the risk of glaucoma progression. The Ocular Hypertension Treatment Study showed that lowering pressure by 20 percent reduced conversion to glaucoma by more than half. The Early Manifest Glaucoma Trial showed that each mmHg reduction in pressure produced a measurable reduction in progression risk.

You are not treating a feeling. You are treating a measurable biological risk that happens to produce no warning before it causes irreversible harm.


“But My Pressures Are Controlled Now — Do I Still Need Drops?”

Yes. Controlled pressure means the treatment is working. Stopping treatment removes the protection. Pressure typically rises again within days to weeks after discontinuation.

Some patients assume that normal pressure readings mean the problem is resolved. Glaucoma is a chronic condition. Controlled pressure is a maintained state, not a cured one.


Normal-Tension Glaucoma: When Pressure Is Not Even the Full Story

A significant group of patients develop glaucoma with eye pressures in the statistically normal range. Their optic nerves are still vulnerable, often due to poor blood flow, structural susceptibility, or other factors. For these patients, the question “but my pressure is fine” does not mean treatment is unnecessary. It means the target pressure needs to be set lower, and other risk factors need attention.

This is one reason that glaucoma management requires individual assessment, not a one-size guideline.


FAQ

If I have no symptoms, does that mean my glaucoma is mild?

Not necessarily. Glaucoma can cause significant optic nerve damage before any symptom appears. The severity of glaucoma is assessed through structural tests like OCT and functional tests like visual fields, not through how your vision feels day to day.

What happens if I skip my glaucoma drops for a few days?

Eye pressure can rise within 24 to 48 hours of stopping treatment. Over time, this pressure exposure adds to cumulative nerve damage. Occasional missed doses are less harmful than long gaps, but no dose-skipping is risk-free in active glaucoma.

Can I know if my glaucoma is getting worse?

Progression is detected through serial OCT scans and visual field testing, not through symptoms. This is why regular follow-up is essential even when your vision feels unchanged.

My doctor wants to change my drops. Should I get a second opinion first?

A second opinion is always appropriate in glaucoma, especially if you are uncertain about treatment changes, surgical recommendations, or whether your current regimen is adequate. Glaucoma causes irreversible loss, so the cost of a wrong decision is permanent.

Are there people who do not need treatment despite a glaucoma diagnosis?

In very early suspected glaucoma or ocular hypertension with low risk factors, observation may be appropriate rather than immediate treatment. This is a clinical judgement based on your individual risk profile, your optic nerve appearance, and your visual field results. It requires an experienced glaucoma specialist to make that call correctly.


What You Should Expect From Your Glaucoma Care

A good glaucoma consultation does more than prescribe drops. It establishes your target pressure based on your stage of disease, your age, and your life expectancy. Also, it identifies your progression rate through serial testing. It reviews whether your current treatment is achieving that target. And it explains, clearly, what is at stake if treatment is inconsistent.

If you have left a consultation without understanding why your specific pressure target was chosen, that is worth asking about. If you are uncertain whether your glaucoma is stable or progressing, that is worth investigating through formal visual field and OCT trend analysis.


A Note on Seeking a Second Opinion

Glaucoma decisions carry permanent consequences. Second opinions are not a sign of distrust toward your current doctor. They are a rational response to a disease where the cost of under-treatment is irreversible. An independent review of your scans and pressure history can confirm that you are on the right path, or catch something that has been missed.


This page is part of the Glaucoma Hub hub. Read about our full approach to glaucoma care. Please also read our Second Opinion Hub. Please also read Glaucoma Diagnosis, first 90 days; and Glaucoma Treatment

Here’s another heartening patient story: Tired of drops


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google